News

The partnership, which will include multiple projects over an initial five-year period, will allow the companies to gain deeper, real-world insight about the experience of these patients. As

Under the long-term strategic partnership, Clinipace will be responsible for managing several clinical programs on behalf of Karyopharm in 2014, including oncology, wound healing, and other diseases. KPTI

In 2012, mental health was the second largest US drug class for spending and in 2011, anti-psychotics and antidepressants accounted for $29.2bn in US sales, with over 264

The deal will combine Greenphire’s ClinCard System with ERT’s electronic patient reported outcomes (ePRO) technology. Greenphire vice president of Product Management Kyle Cunningham said by incorporating the company’s

In the trial, about 623 patients were given once-monthly intramuscular injections of aripiprazole lauroxil 441mg, 882mg or placebo for 12 weeks. Patients treated with either 441mg or 882mg

This agreement is another component of our slate of channel partners that we are strategically aligning ourselves with. Initially Menzer will focus on sales of our Ogiene products

Dr J. Tost’s team at CNG uses novel technologies to analyze gene regulation and epigenetics, specifically DNA methylation. DBV and CEA/CNG will collaborate to characterize the epigenetic modifications

Upset Stomach is the second variant to be launched in the F.A.S.T. range of products and it is formulated to relive upset stomach symptoms. It comes in a

These represent key steps toward achieving the company’s vision to commercialize compounds it has developed to prevent certain types of hearing loss. The company’s product will be the